Epigenomics Profile

2.46
USD 0.00  0.00%
0%

Epigenomics Summary

Epigenomics AG (EPGNF) is traded on OTC Market in USA. It is located in Geneststrasse 5 and employs 43 people. The company currently falls under 'Micro-Cap' category with current market capitalization of 60.43 M. Epigenomics AG has 24.01 M outstanding shares. EPIGENOMICS AG BE has accumulated about 15 M in cash with (8.54 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.73.
Check Epigenomics Probability Of Bankruptcy

Epigenomics Target Price Odds Analysis

Odds Below 2.46HorizonTargetOdds Above 2.46
6.36%30 days 2.46 93.48%
Based on normal probability distribution, the odds of Epigenomics to move above current price in 30 days from now is more than 93.0% (This Epigenomics AG probability density function shows the probability of Epigenomics Stock to fall within a particular range of prices over 30 days) .

Epigenomics AG Risk Profiles

Epigenomics Key Fundamentals

Epigenomics Against Markets

Epigenomics Current Ratings

Epigenomics AG 30 Days Performance Scores

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
1 
Equity ratings for Epigenomics AG are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Epigenomics AG, a molecular diagnostics company, focuses on developing and commercializing in vitro diagnostic tests for the screening, early detection, and diagnosis of cancer in Germany and internationally. Epigenomics AG was founded in 1998 and is headquartered in Berlin, Germany. Epigenomics AG is traded on OTC Market in USA. more
NameEpigenomics AG
CEOGregory HamiltonView All
Macroaxis Advice
InstrumentUSA Stock View All
Business AddressGeneststrasse 5
ExchangeOTC Market
BenchmarkDOW
Websitewww.epigenomics.com
Phone49 30 243 450
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2017
Most Recent QuarterJune 30, 2016
Last Fiscal Year EndDecember 31, 2015

Management

Epigenomics Corporate Management

Antje Zeise Manager Investor Relations
Guenther Reiter Member of the Supervisory Board
Ann Kessler Member of the Supervisory Board
Helge Lubenow Member of the Supervisory Board
Additionally see Investing Opportunities. Please also try Crypto Portfolio Optimizer module to optimize portfolio of digital coins and token across multiple currency and exchanges.
Search macroaxis.com